AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33597147 — intervention group
Group type: EXPERIMENTAL
Intervention: KeepWell (eHealth self-management application)
Number of subjects: 0
Study 33597147 — intervention group
Group type: COMPARATOR
Intervention: Control (survey platform)
Number of subjects: 0
Study 32162607 — intervention group
Group type: EXPERIMENTAL
Intervention: Mg citrate (MgC)
Number of subjects: 14
Study 32162607 — intervention group
Group type: COMPARATOR
Intervention: Mg oxide (MgO)
Number of subjects: 14
Study 36204953 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D‐DSD combined with double positioning crown extension guide
Number of subjects: 20
Study 36204953 — intervention group
Group type: COMPARATOR
Intervention: Traditional aesthetic crown lengthening and full crown restoration
Number of subjects: 20
Study 33907188 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine (serotonin and noradrenaline reuptake inhibitor)
Number of subjects: 4647
Study 32198104 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-Only intervention
Number of subjects: 105
Study 32198104 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient+Partner intervention
Number of subjects: 105
Study 34910143 — intervention group
Group type: EXPERIMENTAL
Intervention: Depot Medroxyprogesterone Acetate (DMPA‐IM)
Number of subjects: 4062
Study 34910143 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper Intrauterine Device (IUD)
Number of subjects: 4062
Study 34910143 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel (LNG) Implant
Number of subjects: 4062
Study 34910143 — intervention group
Group type: COMPARATOR
Intervention: DMPA‐IM
Number of subjects: 4062
Study 34910143 — intervention group
Group type: COMPARATOR
Intervention: Copper IUD
Number of subjects: 4062
Study 34910143 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV acquisition
Number of subjects: 4062
Study 34222059 — intervention group
Group type: COMPARATOR
Intervention: Mindfulness and placebo
Number of subjects: 225
Study 34222059 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 225
Study 34222059 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness
Number of subjects: 225
Study 34222059 — intervention group
Group type: EXPERIMENTAL
Intervention: VD (Vitamin D)
Number of subjects: 225
Study 34222059 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness and VD (Vitamin D)
Number of subjects: 225
Study 35285287 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized approach by clinicians
Number of subjects: 16
Study 35285287 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptations in practice
Number of subjects: 16
Study 35285287 — intervention group
Group type: EXPERIMENTAL
Intervention: Recognition of autism features
Number of subjects: 16
Study 35285287 — intervention group
Group type: EXPERIMENTAL
Intervention: Training on autism adaptations
Number of subjects: 16
Study 32530340 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin adhesive
Number of subjects: 121
Study 32530340 — intervention group
Group type: COMPARATOR
Intervention: Conventional suture
Number of subjects: 121
Study 32868130 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza vaccine
Number of subjects: 0
Study 32868130 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 34802887 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative removal of third molars 6 months prior to BSSO
Number of subjects: 75
Study 34802887 — intervention group
Group type: COMPARATOR
Intervention: Intra-operative removal of contralateral third molars during BSSO
Number of subjects: 75
Study 33928827 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone therapy
Number of subjects: 0
Study 33928827 — intervention group
Group type: COMPARATOR
Intervention: Combined oral contraceptives
Number of subjects: 0
Study 33928827 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone therapy and combined oral contraceptives
Number of subjects: 0
Study 33112264 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic models developed using supervised machine learning algorithms and regression models.
Number of subjects: 158
Study 33112264 — intervention group
Group type: EXPERIMENTAL
Intervention: 19-point score system for stratifying patients according to subtype diagnosis.
Number of subjects: 158
Study 33112264 — intervention group
Group type: EXPERIMENTAL
Intervention: Flow-chart integrating the score system.
Number of subjects: 158
Study 35166800 — intervention group
Group type: COMPARATOR
Intervention: Care Management (n = 6230)
Number of subjects: 18644
Study 35166800 — intervention group
Group type: COMPARATOR
Intervention: Skills Training (n = 6227)
Number of subjects: 18644
Study 35166800 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (n = 6187)
Number of subjects: 18644
Study 35166800 — intervention group
Group type: COMPARATOR
Intervention: Care Management vs Usual Care
Number of subjects: 18644
Study 35166800 — intervention group
Group type: COMPARATOR
Intervention: Skills Training vs Usual Care
Number of subjects: 18644
Study 34139220 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg of body mass)
Number of subjects: 13
Study 34139220 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 32384500 — intervention group
Group type: COMPARATOR
Intervention: 1 dose of intravenous dexamethasone and 1 dose of normal saline (Group A)
Number of subjects: 200
Study 32384500 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 doses of intravenous dexamethasone (Group B)
Number of subjects: 200
Study 36562419 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose fenfluramine
Number of subjects: 10
Study 33630218 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver volume index
Number of subjects: 277
Study 33630218 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram-based prediction score from liver cirrhosis, gamma-glutamyl transferase, and liver volume index
Number of subjects: 277
Study 32627243 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain-related TMD group
Number of subjects: 116
Study 32627243 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed TMD group
Number of subjects: 116
Study 32627243 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular TMD group
Number of subjects: 116
Study 32627243 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 116
Study 35113921 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative Assessment and Management of Suicidality (CAMS)
Number of subjects: 148
Study 35113921 — intervention group
Group type: COMPARATOR
Intervention: Enhanced treatment as usual (ETAU)
Number of subjects: 148
Study 34074895 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-TAVI assessment of the septo-valvular angle (SVA)
Number of subjects: 57
Study 34074895 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of the septo-valvular angle (SVA)
Number of subjects: 57
Study 34074895 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of the muscular septum length (MSL)
Number of subjects: 57
Study 35196580 — intervention group
Group type: EXPERIMENTAL
Intervention: Heating therapy
Number of subjects: 145
Study 35196580 — intervention group
Group type: COMPARATOR
Intervention: Control group (no heating therapy)
Number of subjects: 145
Study 33170576 — intervention group
Group type: EXPERIMENTAL
Intervention: Reheart compression assist device
Number of subjects: 32
Study 33170576 — intervention group
Group type: COMPARATOR
Intervention: Conventional method without Reheart
Number of subjects: 32
Study 35649607 — intervention group
Group type: EXPERIMENTAL
Intervention: Make It Training - Mindfulness-Based and Skills-Based Distress Reduction
Number of subjects: 600
Study 35649607 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual Optimised (TAU-O)
Number of subjects: 600
Study 33448754 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Exercise Group (REG) - performed progressive resistance exercises with elastic bands (24 sessions over 12 weeks)
Number of subjects: 31
Study 33448754 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - only had their symptoms monitored through phone calls, maintaining usual care treatment
Number of subjects: 31
Study 33151780 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium Disilicate (IPS e.max Press) with 4.5 mm occlusal thickness and 2 mm radicular extension
Number of subjects: 90
Study 33151780 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium Disilicate (IPS e.max Press) with 4.5 mm occlusal thickness
Number of subjects: 90
Study 33151780 — intervention group
Group type: EXPERIMENTAL
Intervention: High translucency zirconia (Ceramill Zolid HT) with conventional 2 mm thickness
Number of subjects: 90
Study 33151780 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymer infiltrated ceramic (Vita Enamic)
Number of subjects: 90
Study 33151780 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium Disilicate and Polymer infiltrated ceramic
Number of subjects: 90
Study 33151780 — intervention group
Group type: EXPERIMENTAL
Intervention: High translucency zirconia with 2 mm radicular extension
Number of subjects: 90
Study 35715806 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring toolkit implementation
Number of subjects: 0
Study 33196633 — intervention group
Group type: EXPERIMENTAL
Intervention: Pushing down on the chest wall during defibrillation
Number of subjects: 3
Study 33196633 — intervention group
Group type: EXPERIMENTAL
Intervention: Pushing down on the chest wall during cardioversion
Number of subjects: 3
Study 35287480 — intervention group
Group type: EXPERIMENTAL
Intervention: Yangxin Recipe (YXR) + conventional western medicine
Number of subjects: 78
Study 35287480 — intervention group
Group type: COMPARATOR
Intervention: Conventional western medicine
Number of subjects: 78
Study 32297357 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasensitive ultrasound microvessel imaging (UMI)
Number of subjects: 48
Study 32297357 — intervention group
Group type: COMPARATOR
Intervention: Conventional color flow imaging (CFI)
Number of subjects: 48
Study 35691324 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV‐19 (AZD1222) vaccine, 5 × 10^10 viral particles, two doses
Number of subjects: 262
Study 35691324 — intervention group
Group type: COMPARATOR
Intervention: Capsular group B meningococcal vaccine (control)
Number of subjects: 262
Study 35556001 — intervention group
Group type: EXPERIMENTAL
Intervention: PB125 (100mg)
Number of subjects: 10
Study 35556001 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 34308899 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional physiotherapy (CT)
Number of subjects: 89
Study 34308899 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioception exercises (PE)
Number of subjects: 89
Study 34308899 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined CT and PE (CT&PE)
Number of subjects: 89
Study 34308899 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 89
Study 33965295 — intervention group
Group type: EXPERIMENTAL
Intervention: Variable-angle volar locking plate (VAVLP)
Number of subjects: 120
Study 33965295 — intervention group
Group type: COMPARATOR
Intervention: Fixed-angle volar locking plate (FAVLP)
Number of subjects: 120
Study 33934714 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (1000–3000 mg)
Number of subjects: 176
Study 33934714 — intervention group
Group type: COMPARATOR
Intervention: Fosphenytoin (22.5 mg/kg)
Number of subjects: 176
Study 32156580 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupation-based intervention including physical exercises (OBI)
Number of subjects: 504
Study 32156580 — intervention group
Group type: COMPARATOR
Intervention: Physical exercise-based occupation-focused intervention
Number of subjects: 504
Study 32156580 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with weak SOC
Number of subjects: 504
Study 35149145 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback training (NFT)
Number of subjects: 36
Study 35149145 — intervention group
Group type: COMPARATOR
Intervention: Sham feedback (Control)
Number of subjects: 36
Study 34052232 — intervention group
Group type: EXPERIMENTAL
Intervention: IV sildenafil (loading: 0.1 mg/kg over 30 minutes; maintenance: 0.03 mg/kg/h)
Number of subjects: 59
Study 34052232 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 34052232 — intervention group
Group type: EXPERIMENTAL
Intervention: IV sildenafil
Number of subjects: 59
Study 33926584 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal learning and memory (vLM)
Number of subjects: 349
Study 33926584 — intervention group
Group type: EXPERIMENTAL
Intervention: Processing speed-cognitive flexibility (PSCF)
Number of subjects: 349
Study 33926584 — intervention group
Group type: EXPERIMENTAL
Intervention: Resilience
Number of subjects: 349
Study 32240542 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile text messaging (3 to 5 messages daily for one month)
Number of subjects: 128
Study 32240542 — intervention group
Group type: COMPARATOR
Intervention: Control group (no messages)
Number of subjects: 128
Study 36197388 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug use prevention program #TamoJunto2.0
Number of subjects: 5213
Study 36197388 — intervention group
Group type: EXPERIMENTAL
Intervention: Marijuana use
Number of subjects: 5213
Study 36197388 — intervention group
Group type: EXPERIMENTAL
Intervention: Being a girl
Number of subjects: 5213
Study 36197388 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 5213
Study 34769571 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted learning system (RobotLS)
Number of subjects: 60
Study 34769571 — intervention group
Group type: COMPARATOR
Intervention: Video-assisted learning system (VideoLS)
Number of subjects: 60
Study 32333641 — intervention group
Group type: EXPERIMENTAL
Intervention: MSB11455 (6 mg/0.6 mL)
Number of subjects: 336
Study 32333641 — intervention group
Group type: COMPARATOR
Intervention: Neulasta® (6 mg/0.6 mL)
Number of subjects: 336
Study 32333641 — intervention group
Group type: EXPERIMENTAL
Intervention: MSB11455 and Neulasta®
Number of subjects: 336
Study 33279955 — intervention group
Group type: EXPERIMENTAL
Intervention: Active dual-chamber pacemaker (pacing ON)
Number of subjects: 127
Study 33279955 — intervention group
Group type: COMPARATOR
Intervention: Inactive dual-chamber pacemaker (pacing OFF)
Number of subjects: 127
Study 32164428 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin infusion (0.5 mcg/kg/min)
Number of subjects: 53
Study 32164428 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin infusion
Number of subjects: 53
Study 32164428 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 53
Study 34229259 — intervention group
Group type: EXPERIMENTAL
Intervention: High intake of processed meat
Number of subjects: 415524
Study 34229259 — intervention group
Group type: COMPARATOR
Intervention: 24‐h urinary sodium (UNa)
Number of subjects: 415524
Study 34229259 — intervention group
Group type: COMPARATOR
Intervention: Mendelian randomization analysis of UNa
Number of subjects: 415524
Study 35450681 — intervention group
Group type: EXPERIMENTAL
Intervention: PFHP + TRB
Number of subjects: 443
Study 35450681 — intervention group
Group type: COMPARATOR
Intervention: TRB
Number of subjects: 443
Study 32500486 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg once daily plus Metformin 1000 mg once daily for 12 weeks
Number of subjects: 80
Study 32500486 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine 20 mg once daily plus placebo for 12 weeks
Number of subjects: 80
Study 34097231 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 days of antibiotic therapy
Number of subjects: 70
Study 34097231 — intervention group
Group type: COMPARATOR
Intervention: 14 days of antibiotic therapy
Number of subjects: 70
Study 33770125 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index (BMI) <18.5 kg/m2
Number of subjects: 200
Study 33770125 — intervention group
Group type: EXPERIMENTAL
Intervention: Early coitarche
Number of subjects: 200
Study 33770125 — intervention group
Group type: EXPERIMENTAL
Intervention: History of using oral contraceptive pills
Number of subjects: 200
Study 33770125 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifetime sexual transmitted infections
Number of subjects: 200
Study 33770125 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple sexual partners
Number of subjects: 200
Study 33770125 — intervention group
Group type: COMPARATOR
Intervention: BMI ≥25 kg/m2
Number of subjects: 200
Study 33770125 — intervention group
Group type: COMPARATOR
Intervention: Level of education of college and above
Number of subjects: 200
Study 32954812 — intervention group
Group type: EXPERIMENTAL
Intervention: FreeStyle Libre 2 System
Number of subjects: 273
Study 33291070 — intervention group
Group type: EXPERIMENTAL
Intervention: High Contextual Interference (HCI)
Number of subjects: 35
Study 33291070 — intervention group
Group type: COMPARATOR
Intervention: Low Contextual Interference (LCI)
Number of subjects: 35
Study 35726289 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic retrograde cholangiopancreatography (ERCP) combined with endoscopic sphincterotomy (EST)
Number of subjects: 100
Study 35726289 — intervention group
Group type: COMPARATOR
Intervention: Control group (open surgery)
Number of subjects: 100
Study 34253715 — intervention group
Group type: EXPERIMENTAL
Intervention: tolcapone
Number of subjects: 30
Study 32198342 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (1.5 mg/kg bolus over 30 min, followed by 1 mg/kg/h continuous infusion for 6 h)
Number of subjects: 0
Study 32198342 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study 32198342 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 0
Study 32198342 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 33962592 — intervention group
Group type: EXPERIMENTAL
Intervention: CPI treatment combined with SBRT (Arm A)
Number of subjects: 98
Study 33962592 — intervention group
Group type: COMPARATOR
Intervention: CPI monotherapy (Arm B)
Number of subjects: 98
Study 32997046 — intervention group
Group type: EXPERIMENTAL
Intervention: POC‐CCA test
Number of subjects: 217
Study 32997046 — intervention group
Group type: COMPARATOR
Intervention: RS (16 Kato‐Katz slides and Helmintex® method)
Number of subjects: 217
Study 32997046 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-treatment evaluation
Number of subjects: 217
Study 32997046 — intervention group
Group type: EXPERIMENTAL
Intervention: POC‐CCA test post-treatment
Number of subjects: 217
Study 35766397 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual coaching program (three 1:1 coaching sessions over 9 months)
Number of subjects: 237
Study 35766397 — intervention group
Group type: COMPARATOR
Intervention: Control (e-mailed wellness resources)
Number of subjects: 237
Study 33341955 — intervention group
Group type: EXPERIMENTAL
Intervention: Tegoprazan (50 mg and 100 mg) coadministered with amoxicillin/clarithromycin (1000/500 mg) for 7 days
Number of subjects: 0
Study 33341955 — intervention group
Group type: COMPARATOR
Intervention: Pantoprazole-based triple therapy
Number of subjects: 0
Study 32816839 — intervention group
Group type: EXPERIMENTAL
Intervention: Customised Interactive Computer Education System (CICS)
Number of subjects: 100
Study 32816839 — intervention group
Group type: COMPARATOR
Intervention: Pictorial Information Booklet
Number of subjects: 100
Study 36044101 — intervention group
Group type: EXPERIMENTAL
Intervention: No-ACT group
Number of subjects: 200
Study 36044101 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT group
Number of subjects: 200
Study 36044101 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study 33413594 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg once daily for 36 months
Number of subjects: 554
Study 33413594 — intervention group
Group type: COMPARATOR
Intervention: Matching inactive placebo for 36 months
Number of subjects: 554
Study 36314226 — intervention group
Group type: EXPERIMENTAL
Intervention: CO-OP plus NDT
Number of subjects: 32
Study 36314226 — intervention group
Group type: COMPARATOR
Intervention: NDT
Number of subjects: 32
Study 32860443 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MI)
Number of subjects: 247
Study 32860443 — intervention group
Group type: COMPARATOR
Intervention: Stress management (SM)
Number of subjects: 247
Study 32955410 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (IC)
Number of subjects: 10
Study 32955410 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemotherapy (CC)
Number of subjects: 10
Study 32955410 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemotherapy plus adjuvant chemotherapy (CC + AC)
Number of subjects: 10
Study 32955410 — intervention group
Group type: COMPARATOR
Intervention: Overall comparison of IC, CC, and CC + AC
Number of subjects: 10
Study 35468847 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (single intravenous injection)
Number of subjects: 0
Study 35468847 — intervention group
Group type: COMPARATOR
Intervention: Standard analgesia
Number of subjects: 0
Study 35468847 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32731757 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy
Number of subjects: 72
Study 32731757 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care (ultrasound + hot pack + self‐stretch‐exercises)
Number of subjects: 72
Study 32731757 — intervention group
Group type: COMPARATOR
Intervention: Control (self‐stretch‐exercises)
Number of subjects: 72
Study 32521736 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (SSRI), 6-week treatment
Number of subjects: 16
Study 32521736 — intervention group
Group type: COMPARATOR
Intervention: Placebo, 6-week treatment
Number of subjects: 16
Study 35470201 — intervention group
Group type: EXPERIMENTAL
Intervention: SWEPPE smartphone application for 1 year (n=180)
Number of subjects: 360
Study 35470201 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=180)
Number of subjects: 360
Study 34796851 — intervention group
Group type: COMPARATOR
Intervention: Abatacept
Number of subjects: 213
Study 34796851 — intervention group
Group type: COMPARATOR
Intervention: Rituximab
Number of subjects: 213
Study 34796851 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study 34781008 — intervention group
Group type: EXPERIMENTAL
Intervention: MOCA + 2% POL liquid (2% group)
Number of subjects: 364